Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-David Cohen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Presse Medicale (Paris, France : 1983)|April 15, 2006
[Anti-TNF alpha in the treatment of psoriatic arthritis]Pascal Claudepierre, Daniel Wendling, Jean-David Cohen
Joint Bone Spine|June 9, 2004
Leflunomide-induced aseptic meningitisJean-David Cohen, Christian Jorgensen, Jacques Sany
Clinical Rheumatology|June 24, 2020
Preconceived notions about biosimilars-a French experienceJean-David Cohen, Sonia Tropé, Pascal Paubel, et al.
The Journal of Rheumatology|November 3, 2005
Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary dataCaroline Delaunay, Valérie Farrenq, André Marini-Portugal, et al.
The Journal of Rheumatology|October 3, 2006
Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case seriesJean David Cohen, Irina Bournerias, Valérie Buffard, et al.
The Journal of Rheumatology|January 6, 2006
Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathiesJean-David Cohen, Patrick Cunin, Valérie Farrenq, et al.
The Journal of Rheumatology|August 23, 2006
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritisJean-David Cohen, Maxime Dougados, Philippe Goupille, et al.
Rheumatology (Oxford, England)|July 22, 2009
Medico-economic evaluation of infliximab in rheumatoid arthritis--prospective French study of a cohort of 635 patients monitored for two yearsJacques Sany, Jean-David Cohen, Christophe Combescure, et al.
Joint Bone Spine|January 20, 2019
Patients' information and perspectives on biosimilars in rheumatology: A French nation-wide surveyLéa Frantzen, Jean-David Cohen, Sonia Tropé, et al.
Joint Bone Spine|April 15, 2018
Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseasesClaire I Daïen, Amandine Tubery, Mégane Beurai-Weber, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Presse Medicale (Paris, France : 1983)|April 15, 2006
[Anti-TNF alpha in the treatment of psoriatic arthritis]Pascal Claudepierre, Daniel Wendling, Jean-David Cohen
Joint Bone Spine|June 9, 2004
Leflunomide-induced aseptic meningitisJean-David Cohen, Christian Jorgensen, Jacques Sany
Clinical Rheumatology|June 24, 2020
Preconceived notions about biosimilars-a French experienceJean-David Cohen, Sonia Tropé, Pascal Paubel, et al.
The Journal of Rheumatology|November 3, 2005
Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary dataCaroline Delaunay, Valérie Farrenq, André Marini-Portugal, et al.
The Journal of Rheumatology|October 3, 2006
Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case seriesJean David Cohen, Irina Bournerias, Valérie Buffard, et al.
The Journal of Rheumatology|January 6, 2006
Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathiesJean-David Cohen, Patrick Cunin, Valérie Farrenq, et al.
The Journal of Rheumatology|August 23, 2006
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritisJean-David Cohen, Maxime Dougados, Philippe Goupille, et al.
Rheumatology (Oxford, England)|July 22, 2009
Medico-economic evaluation of infliximab in rheumatoid arthritis--prospective French study of a cohort of 635 patients monitored for two yearsJacques Sany, Jean-David Cohen, Christophe Combescure, et al.
Joint Bone Spine|January 20, 2019
Patients' information and perspectives on biosimilars in rheumatology: A French nation-wide surveyLéa Frantzen, Jean-David Cohen, Sonia Tropé, et al.
Joint Bone Spine|April 15, 2018
Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseasesClaire I Daïen, Amandine Tubery, Mégane Beurai-Weber, et al.
Pageof 2